Vista Pharmaceuticals informs about closure of trading window

25 Mar 2025 Evaluate
Vista Pharmaceuticals has informed that as per the Company's minimum Standards Code of Conduct to regulate, monitor and report trading by its Employees and other Connected Persons under SEBI (Prohibition of Insider Trading)Regulations, 2015 (as amended) (PIT Regulations) and pursuant to BSE Circular Ref No: LIST/COMP/01/2019-20 dated 02nd April, 2019 on the provisions of Clause 4 of the Schedule B of the PIT regulations, the Trading Window for dealing in the Securities of the Company shall remain closed on and from 1st March, 2025 and will re-open after completion of 48 hours from the declaration of audited financial results for the quarter and year ended 31.03.2025 by the Board of Directors of the Company. The same has been intimated to all the directors, officers and designated employees of the company. Further the date of Board Meeting for considering the said financial results for quarter and year ended 31.03.2025, shall be intimated in due course. 

The above information is a part of company’s filings submitted to BSE.



Vista Pharma Share Price

11.24 0.26 (2.37%)
27-Mar-2025 12:46 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1728.05
Dr. Reddys Lab 1150.05
Cipla 1469.85
Lupin 2016.90
Zydus Lifesciences 889.50
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...